Skyepharma | FDA | Inspections | Form 483 | Warning Letters | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Skyepharma
FDA

Skyepharma-PSE

Skyepharma French CDMO Drives Growth Through Leadership Change

06 Nov 2025

// PRESS RELEASE

Skyepharma Expands Oncology Operational Facility in France

16 May 2025

// PRESS RELEASE

Skyepharma CDMO makes debut at Nordic Life Science Days

23 Nov 2023

// PHARMA NETWORKING

Data Compilation
#PharmaFlow

Skyepharma RM

Contact Supplier

34th NZW-Hamburg

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/GQ0e9Im32aY?si=o0xfkcMVN68jYcuM

Skyepharma

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation, French CDMO Drives Growth Through Leadership Change, Skyepharma Strengthens Oncology with New France Facility, Controlling Lag-time & Release Kinetics of Press-coated Tablets , Microfluidization - Skyepharma Collaboration with Lyon University, GMP Certificate 2024, Leading Pharmaceutical Development in a Sustainable Way, Skyepharma & MaaT Pharma launches a facility for Biotherapies, Services, Quality By Design & Expertise, Compaction Simulation Expertise

Corporate Presentation
French CDMO Drives Growth Through Leadership Change
Skyepharma Strengthens Oncology with New France Facility
Controlling Lag-time & Release Kinetics of Press-coated Tablets
Microfluidization - Skyepharma Collaboration with Lyon University
GMP Certificate 2024
Leading Pharmaceutical Development in a Sustainable Way
Skyepharma & MaaT Pharma launches a facility for Biotherapies
Services
Quality By Design & Expertise
Compaction Simulation Expertise

VIDEO(s)

HPAPI Area for Immuno-oncological Treatments, CDMO Expert in Complex Oral Solid Dosage Forms, Interview CPhI WW 2022, Services Presentation, Corporate Video - Center of Excellence, Agile CDMO Partner, Fully Integrated CDMO, Manufacturing Capabilities, Microfluidizer Technology, Pharmaceutical Development Services, Reliable CDMO Partner, Soctec® Technology, Pharmapack 2020- Interview with David Lescuyer, Packaging Services 2020, CPhI Worldwide 2018

HPAPI Area for Immuno-oncological Treatments
CDMO Expert in Complex Oral Solid Dosage Forms
Interview CPhI WW 2022
Services Presentation
Corporate Video - Center of Excellence
Agile CDMO Partner
Fully Integrated CDMO
Manufacturing Capabilities
Microfluidizer Technology
Pharmaceutical Development Services
Reliable CDMO Partner
Soctec® Technology
Pharmapack 2020- Interview with David Lescuyer
Packaging Services 2020
CPhI Worldwide 2018

DIGITAL CONTENT

2 Interview #SpeakPharma, 26 Corporate Content #SupplierSpotlight, 1 Data Compilation #PharmaFlow, 36 News #PharmaBuzz

2 Interview #SpeakPharma
26 Corporate Content #SupplierSpotlight
1 Data Compilation #PharmaFlow
36 News #PharmaBuzz

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 3 FDA Orange Book

3 FDF Dossiers
3 FDA Orange Book

SERVICES

Analytical, Drug Product Manufacturing, Sales, Marketing, Registration, Packaging, API & Drug Product Development

Analytical
- 1 Analytical Method Development
Drug Product Manufacturing
Sales, Marketing, Registration
- 1 Regulatory Affairs / Pharmacovigilance
Packaging
- 4 Contract Services
API & Drug Product Development
- 5 Formulation Development

KEY SERVICES

Modified Release Capsules, GEOMATRIX: Multi-layer Tablet Technology, SOCTEC - ER Gastro-retentive Technology, Immediate & Modified Release Tablets, Controlled Drug Delivery, GEOCLOCK - Tab-in-Tab Technology, Highly Potent Tablet Manufacturing, Complex OSD Manufacturing, ODT Manufacturing, Chewable Tablet Manufacturing, Bioproduction, Highly Potent Capsule Manufacturing

Modified Release Capsules
GEOMATRIX: Multi-layer Tablet Technology
SOCTEC - ER Gastro-retentive Technology
Immediate & Modified Release Tablets
Controlled Drug Delivery
GEOCLOCK - Tab-in-Tab Technology
Highly Potent Tablet Manufacturing
Complex OSD Manufacturing
ODT Manufacturing
Chewable Tablet Manufacturing
Bioproduction
Highly Potent Capsule Manufacturing

INSPECTIONS & REGISTRATIONS

6 FDA, 5 EDQM, 1 GDUFA

6 FDA
5 EDQM
1 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

6 All

01 1SkyePharma AG

02 5SkyePharma Production SAS

filter District Decision Reset all filters

6 All

01 4No Action Indicated

02 2Voluntary Action Indicated

filter Inspection End Date Reset all filters

6 All

01 12023-10-27

02 12019-09-06

03 12015-06-19

04 12013-05-31

05 12010-04-02

06 12009-09-18

filter City Reset all filters

6 All

01 1Muttenz

02 5St Quentin Fallavier

filter Country/Area Reset all filters

6 All

01 5France

02 1Switzerland

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : Voluntary Action Indicated

Inspection End Date : 2023-10-27

City : St Quentin Fallavier

State :

Country/Area : France

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2023-10-27

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : No Action Indicated

Inspection End Date : 2019-09-06

City : St Quentin Fallavier

State :

Country/Area : France

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2019-09-06

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : No Action Indicated

Inspection End Date : 2015-06-19

City : St Quentin Fallavier

State :

Country/Area : France

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2015-06-19

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : No Action Indicated

Inspection End Date : 2013-05-31

City : St Quentin Fallavier

State :

Country/Area : France

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2013-05-31

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-04-02

City : St Quentin Fallavier

State :

Country/Area : France

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-04-02

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

FDA Audited

USA

34th NZW-Hamburg

Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

District Decision : No Action Indicated

Inspection End Date : 2009-09-18

City : Muttenz

State :

Country/Area : Switzerland

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2009-09-18

Skyepharma Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.